Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 95
Filter
1.
Clinics (Sao Paulo) ; 79: 100463, 2024.
Article in English | MEDLINE | ID: mdl-39111190

ABSTRACT

OBJECTIVE: Pleural effusion is a common medical problem. It is important to decide whether the pleural fluid is a transudate or an exudate. This study aims to measure the attenuation values of pleural effusions on thorax computed tomography and to investigate the efficacy of this measurement in the diagnostic separation of transudates and exudates. MATERIALS AND METHODS: 380 cases who underwent thoracentesis and thorax computed tomography with pleural effusion were classified as exudates or transudates based on Light's criteria. Attenuation measurements in Hounsfield units were performed through the examination of thorax computed tomography images. RESULTS: 380 patients were enrolled (39 % women), the mean age was 69.9 ± 15.2 years. 125 (33 %) were transudates whereas 255 (67 %) were exudates. The attenuation values of exudates were significantly higher than transudates (15.1 ± 5.1 and 5.0 ± 3.4) (p < 0.001). When the attenuation cut-off was set at ≥ 10 HU, exudates were differentiated from transudates at high efficiency (sensitivity is 89.7 %, specificity is 94.4 %, PPV is 97 %, NPV is 81.9 %). When the cut-off value was accepted as < 6 HU, transudates were differentiated from exudates with 97.2 % specificity. CONCLUSION: The attenuation measurements of pleural fluids can be considered as an efficacious way of differentiating exudative and transudative pleural effusions.


Subject(s)
Exudates and Transudates , Pleural Effusion , Sensitivity and Specificity , Tomography, X-Ray Computed , Humans , Female , Pleural Effusion/diagnostic imaging , Male , Exudates and Transudates/diagnostic imaging , Aged , Diagnosis, Differential , Middle Aged , Tomography, X-Ray Computed/methods , Aged, 80 and over , Thoracentesis/methods , Reproducibility of Results , Reference Values , Adult
4.
Respir Med ; 220: 107456, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37926179

ABSTRACT

The pulmonary manifestations of Systemic Lupus Erythematosus (SLE) in pediatric patients are poorly understood and the pulmonary manifestations reported from the adult population are generally extrapolated to the pediatric population. In the present work, the review of 228 files was carried out, in which the pulmonary manifestations, symptoms and antibody levels of the patients treated at the Hospital Regional de Alta Especialidad de Ixtapaluca (HRAEI), State of Mexico, Mexico, were identified. Statistical significance between groups was estimated using the Chi-square and Mann-Whitney U test. The main pulmonary manifestations identified were pleurisy (14 %), pulmonary hemorrhage (3.9 %), pulmonary thromboembolism (0.9 %), acute lupus pneumonitis (0.4 %), pulmonary arterial hypertension (0.4 %), and small lung syndrome (0.4 %). While the initial symptomatology was dyspnea with an incidence of 9.6 %, the mean oxygen saturation in the population was 96.87 %. Pleural effusion was identified as the most frequent pulmonary manifestation in radiographic changes. No statistically significant difference was found in antibody levels when comparing the groups. The most common pulmonary manifestation associated with SLE is pleurisy, however, the range of pulmonary manifestations in this type of patient can be very varied, as well as the presentation of each of them.


Subject(s)
Lung Diseases , Lupus Erythematosus, Systemic , Pleural Effusion , Pleurisy , Adult , Humans , Child , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/epidemiology , Lung Diseases/diagnostic imaging , Lung Diseases/epidemiology , Lung Diseases/etiology , Lung/diagnostic imaging , Pleurisy/etiology , Pleurisy/complications , Pleural Effusion/diagnostic imaging , Pleural Effusion/epidemiology , Pleural Effusion/etiology
5.
BMC Infect Dis ; 23(1): 327, 2023 May 15.
Article in English | MEDLINE | ID: mdl-37189054

ABSTRACT

BACKGROUND: Identification of pleural effusion (PE) in dengue infection is an objective measure of plasma leakage and may predict disease progression. However, no studies have systematically assessed the frequency of PE in patients with dengue, and whether this differs across age and imaging modality. METHODS: We searched Pubmed, Embase Web of Science and Lilacs (period 1900-2021) for studies reporting on PE in dengue patients (hospitalized and outpatient). We defined PE as fluid in the thoracic cavity detected by any imaging test. The study was registered in PROSPERO (CRD42021228862). Complicated dengue was defined as hemorrhagic fever, dengue shock syndrome or severe dengue. RESULTS: The search identified 2,157 studies of which 85 studies were eligible for inclusion. The studies (n = 31 children, n = 10 adults, n = 44 mixed age) involved 12,800 patients (30% complicated dengue). The overall frequency of PE was 33% [95%CI: 29 to 37%] and the rate of PE increased significantly with disease severity (P = 0.001) such that in complicated vs. uncomplicated dengue the frequencies were 48% and 17% (P < 0.001). When assessing all studies, PE occurred significantly more often in children compared to adults (43% vs. 13%, P = 0.002) and lung ultrasound more frequently detected PE than conventional chest X-ray (P = 0.023). CONCLUSIONS: We found that 1/3 of dengue patients presented with PE and the frequency increased with severity and younger age. Importantly, lung ultrasound demonstrated the highest rate of detection. Our findings suggest that PE is a relatively common finding in dengue and that bedside imaging tools, such as lung ultrasound, potentially may enhance detection.


Subject(s)
Dengue , Pleural Effusion , Severe Dengue , Adult , Child , Humans , Severe Dengue/complications , Severe Dengue/diagnostic imaging , Severe Dengue/epidemiology , Exudates and Transudates , Pleural Effusion/diagnostic imaging , Pleural Effusion/epidemiology , Pleural Effusion/complications , Plasma , Ultrasonography , Dengue/complications , Dengue/diagnostic imaging , Dengue/epidemiology
6.
Clinics (Sao Paulo) ; 78: 100210, 2023.
Article in English | MEDLINE | ID: mdl-37149920

ABSTRACT

BACKGROUND: The pleura is a serous membrane that surrounds the lungs. The visceral surface secretes fluid into the serous cavity and the parietal surface ensures a regular absorption of this fluid. If this balance is disturbed, fluid accumulation occurs in the pleural space called "Pleural Effusion". Today, accurate diagnosis of pleural diseases is becoming more critical, as advances in treatment protocols have contributed positively to prognosis. Our aim is to perform computer-aided numerical analysis of Computed Tomography (CT) images from patients showing pleural effusion images on CT and to examine the prediction of malignant/benign distinction using deep learning by comparing with the cytology results. METHODS: The authors classified 408 CT images from 64 patients whose etiology of pleural effusion was investigated using the deep learning method. 378 of the images were used for the training of the system; 15 malignant and 15 benign CT images, which were not included in the training group, were used as the test. RESULTS: Among the 30 test images evaluated in the system; 14 of 15 malignant patients and 13 of 15 benign patients were estimated with correct diagnosis (PPD: 93.3%, NPD: 86.67%, Sensitivity: 87.5%, Specificity: 92.86%). CONCLUSION: Advances in computer-aided diagnostic analysis of CT images and obtaining a pre-diagnosis of pleural fluid may reduce the need for interventional procedures by guiding physicians about which patients may have malignancies. Thus, it is cost and time-saving in patient management, allowing earlier diagnosis and treatment.


Subject(s)
Deep Learning , Pleural Effusion, Malignant , Pleural Effusion , Humans , Pleural Effusion, Malignant/diagnostic imaging , Pleural Effusion/diagnostic imaging , Tomography, X-Ray Computed/methods , Lung
7.
J Pediatr ; 261: 113333, 2023 10.
Article in English | MEDLINE | ID: mdl-36736585

ABSTRACT

OBJECTIVE: To evaluate the association between consolidation on chest radiograph and typical bacterial etiology of childhood community acquired pneumonia (CAP) in the Etiology of Pneumonia in the Community study. STUDY DESIGN: Hospitalized children <18 years of age with CAP enrolled in the Etiology of Pneumonia in the Community study at 3 children's hospitals between January 2010 and June 2012 were included. Testing of blood and respiratory specimens used multiple modalities to identify typical and atypical bacterial, or viral infection. Study radiologists classified chest radiographs (consolidation, other infiltrates [interstitial and/or alveolar], pleural effusion) using modified World Health Organization pneumonia criteria. Infiltrate patterns were compared according to etiology of CAP. RESULTS: Among 2212 children, there were 1302 (59%) with consolidation with or without other infiltrates, 910 (41%) with other infiltrates, and 296 (13%) with pleural effusion. In 1795 children, at least 1 pathogen was detected. Among these patients, consolidation (74%) was the most frequently observed pattern (74% in typical bacterial CAP, 58% in atypical bacterial CAP, and 54% in viral CAP). Positive and negative predictive values of consolidation for typical bacterial CAP were 12% (95% CI 10%-15%) and 96% (95% CI 95%-97%) respectively. In a multivariable model, typical bacterial CAP was associated with pleural effusion (OR 7.3, 95% CI 4.7-11.2) and white blood cell ≥15 000/mL (OR 3.2, 95% CI 2.2-4.9), and absence of wheeze (OR 0.5, 95% CI 0.3-0.8) or viral detection (OR 0.2, 95% CI 0.1-0.4). CONCLUSIONS: Consolidation predicted typical bacterial CAP poorly, but its absence made typical bacterial CAP unlikely. Pleural effusion was the best predictor of typical bacterial infection, but too uncommon to aid etiology prediction.


Subject(s)
Community-Acquired Infections , Pleural Effusion , Pneumonia , Radiology , Humans , Child , Pneumonia/diagnostic imaging , Pneumonia/epidemiology , Pneumonia/etiology , Radiography , Pleural Effusion/diagnostic imaging , Pleural Effusion/etiology , Causality , Community-Acquired Infections/diagnostic imaging , Community-Acquired Infections/etiology
8.
Rev. cuba. pediatr ; 952023. ilus, tab
Article in Spanish | LILACS, CUMED | ID: biblio-1515282

ABSTRACT

Introducción: La inflamación de la pleura desencadenada por bacterias y mediada por citocinas, aumenta la permeabilidad vascular y produce vasodilatación, lo cual genera desequilibrio entre la producción de líquido pleural y su capacidad de reabsorción por eficientes mecanismos fisiológicos. La condición anterior conduce al desarrollo de derrame pleural paraneumónico. Objetivo: Exponer la importancia de la correlación fisiopatológica y diagnóstica con los pilares fundamentales de actuación terapéutica en el derrame pleural paraneumónico. Métodos: Revisión en PubMed y Google Scholar de artículos publicados hasta abril de 2021 que abordaran el derrame pleural paraneumónico, su fisiopatología, elementos diagnósticos, tanto clínicos como resultados del estudio del líquido pleural, pruebas de imágenes, y estrategias terapéuticas. Análisis y síntesis de la información: El progreso de una infección pulmonar y la producción de una invasión de gérmenes al espacio pleural favorece la activación de mecanismos que conllevan al acúmulo de fluido, depósito de fibrina y formación de septos. Este proceso patológico se traduce en manifestaciones clínicas, cambios en los valores citoquímicos y resultados microbiológicos en el líquido pleural, que acompañados de signos radiológicos y ecográficos en el tórax, guían la aplicación oportuna de los pilares de tratamiento del derrame pleural paraneumónico. Conclusiones: Ante un derrame pleural paraneumónico, con tabiques o partículas en suspensión en la ecografía de tórax, hallazgo de fibrina, líquido turbio o pus en el proceder de colocación del drenaje de tórax, resulta necesario iniciar fibrinólisis intrapleural. Cuando el tratamiento con fibrinolíticos intrapleurales falla, la cirugía video-toracoscópica es el procedimiento quirúrgico de elección(AU)


Introduction: The inflammation of the pleura triggered by bacteria and mediated by cytokines, increases vascular permeability and produces vasodilation, which generates imbalance between the production of pleural fluid and its resorption capacity by efficient physiological mechanisms. The above condition leads to the development of parapneumonic pleural effusion. Objective: To expose the importance of the pathophysiological and diagnostic correlation with the fundamental pillars of therapeutic action in parapneumonic pleural effusion. Methods: Review in PubMed and Google Scholar of articles published until April 2021 that addressed parapneumonic pleural effusion, its pathophysiology, diagnostic elements, both clinical and results of the pleural fluid study, imaging tests, and therapeutic strategies. Analysis and synthesis of information: The progress of a lung infection and the production of an invasion of germs into the pleural space favors the activation of mechanisms that lead to the accumulation of fluid, fibrin deposition and formation of septa. This pathological process results in clinical manifestations, changes in cytochemical values and microbiological results in the pleural fluid, which accompanied by radiological and ultrasound signs in the chest, guide the timely application of the pillars of treatment of parapneumonic pleural effusion. Conclusions: In the event of a parapneumonic pleural effusion, with septums or particles in suspension on chest ultrasound, finding fibrin, turbid fluid or pus in the procedure of placement of the chest drain, it is necessary to initiate intrapleural fibrinolytic. When treatment with intrapleural fibrinolytics fails, video-thoracoscopic surgery is the surgical procedure of choice(AU)


Subject(s)
Humans , Pleural Effusion/classification , Pleural Effusion/physiopathology , Pleural Effusion/drug therapy , Pleural Effusion/diagnostic imaging , Drainage/instrumentation , Anti-Bacterial Agents
9.
Radiologia (Engl Ed) ; 64(5): 484-488, 2022.
Article in English | MEDLINE | ID: mdl-36243448

ABSTRACT

Melioidosis is an endemic disease in Southeast Asia and Oceania caused by the gram-negative bacillus Burkholderia pseudomallei. We studied 15 adult patients from Colombia with microbiologically diagnosed pulmonary melioidosis. We reviewed 15 chest X-rays and 10 chest computed tomography (CT) studies. Of the 15 patients, 87% met the criteria for acute infection and 13% met the criteria for chronic infection. The most common findings on chest X-rays were consolidation (86%), nodules (26%), and cavitation (20%). On CT studies, consolidation and nodules were observed in 90% of cases; the areas of consolidation were predominantly located in the basal and central zones in 60%. Areas of cavitation were observed in 50%, pleural effusion in 60%, and mediastinal lymph nodes in 30%. In patients with acute pulmonary melioidosis (n=8), the findings observed were nodules (100%), mixed pattern with nodules and consolidation (87%), pleural effusion (88%), and mediastinal lymph nodes (25%). The two patients with chronic pulmonary melioidosis both had cavitation. Acute lung infection with B. Pseudomallei has radiologic manifestations similar to those of pneumonia due to other causes. In areas where the disease is endemic, it is essential to include acute melioidosis in the differential diagnosis of pulmonary nodules and chronic melioidosis in the differential diagnosis of cavitated chronic lung lesions.


Subject(s)
Burkholderia pseudomallei , Lung Diseases , Melioidosis , Pleural Effusion , Pneumonia , Tuberculosis, Pleural , Adult , Humans , Lung Diseases/diagnostic imaging , Melioidosis/diagnostic imaging , Melioidosis/epidemiology , Pleural Effusion/diagnostic imaging , Pleural Effusion/etiology
12.
Cir Cir ; 89(S2): 17-21, 2021.
Article in English | MEDLINE | ID: mdl-34932528

ABSTRACT

Urinothorax is an unusual cause of pleural effusion. To describe a case with urinothorax secondary to urinary system trauma. 41-year-old male readmitted to our hospital 16 days after a right percutaneous nephrolithotomy with fever, shortness of breath, chest pain and multiloculated pleural effusion confirmed by CT scan, resolved with surgical treatment. Readmitted twenty-one days later with recurrent empyema and diagnosis of reno-pleural fistula, treated with new thoracotomy and double J and urinary catheter placement. The suspected diagnosis and the multidisciplinary approach allowed to solve this rare complication.


El urinotórax es una causa inusual de derrame pleural. Se describe un caso de urinotórax secundario a trauma del sistema urinario. Varón de 41 años que reingresa en el hospital a los 16 días de someterse a una nefrolitotomía percutánea derecha, con fiebre, disnea y dolor torácico. Se confirma por tomografía derrame pleural multitabicado, que se resolvió con tratamiento quirúrgico. Reingresa 21 días después con empiema recidivante y se diagnostica una fístula renopleural, que fue tratada con retoracotomía y colocación de catéter doble J y sonda vesical. La sospecha diagnóstica y el manejo multidisciplinario permitieron resolver esta rara complicación.


Subject(s)
Fistula , Nephrolithotomy, Percutaneous , Pleural Effusion , Adult , Humans , Kidney , Male , Neoplasm Recurrence, Local , Nephrolithotomy, Percutaneous/adverse effects , Pleural Effusion/diagnostic imaging , Pleural Effusion/etiology
13.
Ultrasound Med Biol ; 47(11): 3283-3290, 2021 11.
Article in English | MEDLINE | ID: mdl-34366186

ABSTRACT

Chronic liver disease (CLD) may be associated with pleural effusions (PEs). This article prospectively evaluates whether detection of PEs on thoracic ultrasound (TUS) at the bedside independently predicts mortality and length of stay (LOS) in hospitalized patients with a decompensated CLD. A total of 116 consecutive inpatients with decompensated cirrhosis underwent antero-posterior chest radiographs (CXR) and TUS to detect PEs. Their median age was 54 y (interquartile range, 47-62), 90 (70.6%) were male, and 61 (52.6%) fell into the Child-Pugh class C categorization. TUS identified PEs in 58 (50%) patients, half of which were small enough to preclude thoracentesis. CXR failed to recognize approximately 40% of PEs seen on TUS. The identification of PEs by TUS was associated with a longer LOS (10 vs. 5.5 d, p < 0.001) and double mortality (39.7% vs. 20.7%, p = 0.021). In multivariate analysis, PEs were independently related to poor survival (hazard ratio 2.08, 95% confidence interval [CI] 1.02-4.25; p = 0.044). Patients with both Child-Pugh C stage and PEs had the lowest survival rate (70 vs. 317 d, p = 0.001). In conclusion, PEs identified by TUS in hospitalized patients with decompensated CLD independently predict a poor outcome and portend a longer LOS.


Subject(s)
Pleural Effusion , Point-of-Care Systems , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/diagnostic imaging , Male , Middle Aged , Pleural Effusion/diagnostic imaging , Point-of-Care Testing , Ultrasonography
14.
Am J Forensic Med Pathol ; 42(1): 1-8, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33416234

ABSTRACT

ABSTRACT: The 2019 novel coronavirus disease (COVID-19) has spread worldwide, infiltrating, infecting, and devastating communities in all locations of varying demographics. An overwhelming majority of published literature on the pathologic findings associated with COVID-19 is either from living clinical cohorts or from autopsy findings of those who died in a medical care setting, which can confound pure disease pathology. A relatively low initial infection rate paired with a high biosafety level enabled the New Mexico Office of the Medical Investigator to conduct full autopsy examinations on suspected COVID-19-related deaths. Full autopsy examination on the first 20 severe acute respiratory syndrome coronavirus 2-positive decedents revealed that some extent of diffuse alveolar damage in every death due to COVID-19 played some role. The average decedent was middle-aged, male, American Indian, and overweight with comorbidities that included diabetes, ethanolism, and atherosclerotic and/or hypertensive cardiovascular disease. Macroscopic thrombotic events were seen in 35% of cases consisting of pulmonary thromboemboli and coronary artery thrombi. In 2 cases, severe bacterial coinfections were seen in the lungs. Those determined to die with but not of severe acute respiratory syndrome coronavirus 2 infection had unremarkable lung findings.


Subject(s)
COVID-19/mortality , Lung/pathology , Adult , Age Distribution , Aged , Aged, 80 and over , Autopsy , Body Mass Index , Brain Edema/pathology , Cardiomegaly/pathology , Comorbidity , Coronary Thrombosis/pathology , Databases, Factual , Fatty Liver/pathology , Female , Forensic Pathology , Glomerulosclerosis, Focal Segmental/pathology , Hepatomegaly/pathology , Humans , Lung/diagnostic imaging , Male , Middle Aged , Nephrosclerosis/pathology , New Mexico/epidemiology , Overweight/epidemiology , Pandemics , Pleural Effusion/diagnostic imaging , Pleural Effusion/pathology , Pulmonary Edema/diagnostic imaging , Pulmonary Edema/pathology , Sex Distribution , Streptococcus pneumoniae/isolation & purification , Tomography, X-Ray Computed , Vitreous Body/chemistry , Whole Body Imaging
15.
BMJ Case Rep ; 14(1)2021 Jan 28.
Article in English | MEDLINE | ID: mdl-33509855

ABSTRACT

Infection by human T-lymphotropic virus 1 (HTLV-1) is often seen as the cause of chronic infection or lymphoproliferative disorders, but many clinicians do not recognise its association with severe immunosuppression. We report the case of a woman in her 70s from the Caribbean who sought care at the emergency department for weakness, fatigue and weight loss. Further work-up showed atypical lymphocytosis with floral lymphocytes and smudge cells in the peripheral blood smear and hypercalcaemia. Chest CT demonstrated a moderate right pleural effusion. Results of HIV testing were negative, and screening and confirmatory tests for HTLV-1 were positive. Empiric antibiotic therapy was administered, and the patient was discharged home. Five days later, she was readmitted with shortness of breath and severe abdominal pain. A disseminated infection with Cryptococcus neoformans was diagnosed. Despite aggressive intravenous antifungal therapy, the patient died on day 7 of hospitalisation.


Subject(s)
Cryptococcosis/diagnosis , HTLV-I Infections/diagnosis , Invasive Fungal Infections/diagnosis , Leukemia-Lymphoma, Adult T-Cell/diagnosis , Aged , Antifungal Agents/therapeutic use , Ascites/diagnostic imaging , Cryptococcosis/complications , Cryptococcosis/drug therapy , Emigrants and Immigrants , Fatal Outcome , Female , HTLV-I Infections/complications , Haiti/ethnology , Human T-lymphotropic virus 1 , Humans , Invasive Fungal Infections/complications , Invasive Fungal Infections/drug therapy , Leukemia-Lymphoma, Adult T-Cell/complications , Lymphadenopathy/diagnostic imaging , Pleural Effusion/diagnostic imaging
16.
Biomedica ; 40(Supl. 2): 27-33, 2020 10 30.
Article in English, Spanish | MEDLINE | ID: mdl-33152185

ABSTRACT

COVID-19 is the viral infection caused by SARS-CoV-2 declared by the World Health Organization (WHO) as a pandemic. Patients with cancer have a higher risk to acquire the infection and worse prognosis as they have to attend more medical visits in healthcare institutions, receive medical and surgical treatments, and be subjected to diagnostic studies such as PET/CT in nuclear medicine services where the infection may be an incidental finding. We present here F18-FDG PET/CT (Positron Emission Tomography and Computed Tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose), images with findings of COVID-19 from patients with different oncological conditions but no respiratory symptoms.


La COVID-19 es la infección viral causada por el SARS-CoV-2 y declarada por la Organización Mundial de la Salud (OMS) como pandemia. Los pacientes con cáncer tienen un mayor riesgo de adquirir la infección y un peor pronóstico, ya que deben asistir a visitas médicas en diferentes centros hospitalarios, reciben tratamientos médicos y quirúrgicos y deben someterse a estudios diagnósticos como la PET/CT en servicios de medicina nuclear, lo que es ocasión para el hallazgo incidental de la infección. Se presentan las imágenes de tomografías computarizadas por emisión de positrones con 18-fluorodesoxiglucosa (F18) (Positron Emission Tomography and Computed Tomography with 2-deoxy-2-[fluorine-18]fluoro-D-glucose, PET/CT F18-FDG) en las que se evidenció la COVID-19 en pacientes con diversas enfermedades oncológicas, pero sin sintomatología respiratoria.


Subject(s)
Betacoronavirus/isolation & purification , Coronavirus Infections/diagnostic imaging , Incidental Findings , Neoplasms/complications , Pneumonia, Viral/diagnostic imaging , Positron Emission Tomography Computed Tomography , Adult , Aged , Asymptomatic Diseases , COVID-19 , COVID-19 Testing , Carcinoma, Signet Ring Cell/complications , Carcinoma, Signet Ring Cell/diagnostic imaging , Carcinoma, Signet Ring Cell/secondary , Clinical Laboratory Techniques , Coronavirus Infections/complications , Coronavirus Infections/diagnosis , Female , Fluorine Radioisotopes , Fluorodeoxyglucose F18 , Humans , Lymphatic Metastasis/diagnostic imaging , Lymphoma, Non-Hodgkin/complications , Lymphoma, Non-Hodgkin/diagnostic imaging , Male , Middle Aged , Neoplasms/diagnostic imaging , Pandemics , Pleural Effusion/diagnostic imaging , Pleural Effusion/etiology , Pneumonia, Viral/complications , Radiopharmaceuticals , Reverse Transcriptase Polymerase Chain Reaction , SARS-CoV-2 , Seminoma/complications , Seminoma/diagnostic imaging , Seminoma/secondary , Stomach Neoplasms
18.
Einstein (Sao Paulo) ; 18: eRW5741, 2020.
Article in English, Portuguese | MEDLINE | ID: mdl-32578687

ABSTRACT

The disease caused by the new coronavirus, or COVID-19, has been recently described and became a health issue worldwide. Its diagnosis of certainty is given by polymerase chain reaction. High-resolution computed tomography, however, is useful in the current context of pandemic, especially for the most severe cases, in assessing disease extent, possible differential diagnoses and searching complications. In patients with suspected clinical symptoms and typical imaging findings, in which there is still no laboratory test result, or polymerase chain reaction is not available, the role of this test is still discussed. In addition, it is important to note that part of the patients present false-negative laboratory tests, especially in initial cases, which can delay isolation, favoring the spread of the disease. Thus, knowledge about the COVID-19 and its imaging manifestations is extremely relevant for all physicians involved in the patient care, clinicians or radiologists.


Subject(s)
Coronavirus Infections/diagnostic imaging , Lung/diagnostic imaging , Pneumonia, Viral/diagnostic imaging , Thorax/diagnostic imaging , Tomography, X-Ray Computed , Betacoronavirus , COVID-19 , Diagnosis, Differential , Humans , Lymphadenopathy/diagnostic imaging , Pandemics , Pleural Effusion/diagnostic imaging , SARS-CoV-2
19.
Article in English | MEDLINE | ID: mdl-32491141

ABSTRACT

This is a fatal case of fungaemia due to Cryptococcus albidus in an elderly woman with type 2 diabetes mellitus who presented pleural effusion as the only clinical presentation. Not only infections of the pleura are uncommon presentations of pulmonary cryptococcosis, but these infections due to non-C. neoformans species are extremely rare. This report places C. albidus on the growing number of disseminated mycosis-causing agents in diabetic patients.


Subject(s)
Cryptococcus/isolation & purification , Diabetes Mellitus, Type 2/microbiology , Fungemia/microbiology , Pleural Effusion/microbiology , Aged, 80 and over , Fatal Outcome , Female , Humans , Pleural Effusion/diagnostic imaging , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL